Skip to main content
x

MSBID-AT Program

M.S. in Biomedical Innovation and Development - Advanced Therapeutics

 

The new Master of Science in Biomedical Innovation and Development – Advanced Therapeutics (MSBID-AT) will be a full-time residential program completed in three sequential semesters over 12 months (summer, fall, spring) at Emory University.

This industry-focused program will train the next generation of leaders in bringing medical breakthroughs to the patient. Distinct from programs in drug discovery or vaccine development, our advanced therapeutics degree focuses on the emergent industries of cell therapy, gene therapy, tissue engineering, and regenerative medicine.

Trainees in the MSBID-AT program will learn at the interface of advanced therapeutics, healthcare, and business management, developing the skills they need to hit the ground running in this industry and spur advanced therapeutics innovation.

The program is focused on training an emerging workforce in the translation of innovative advanced therapeutics from the lab to the bedside.

Interested in biomedical engineering devices and technology? Check out our Georgia Tech MBID program.

The MSBID-AT program at Emory builds a broad foundation that includes training, professional development, and career planning so you’re ready for a dynamic, fast-growing field.

Potential Career Paths:

  • Product Development / R&D
  • Discovery Scientist
  • Manufacturing Scientist / Engineer
  • Quality Engineer / Scientist
  • Pre-Clinical Operations
  • Clinical Operations and Regulatory Consultation
  • Medical Affairs / Clinical Communications
  • Marketing
  • Clinical Sciences / Technical Sales Support

 

Candidates for this master’s program include:

  • Aspiring students who wish to pursue a career in advanced therapeutics in industry, startups, or regulatory agencies.
  • Early-career professionals working in biomedicine.
  • High-performing recent graduates with undergraduate or graduate degrees in engineering, science, or medicine.

Join our mailing list to be notified when applications open in Fall 2022 for our first cohort (enrolling for Summer 2023).

 

SIGN UP

Application and admission materials for the M.S. in Biomedical Innovation and Development - Advanced Therapeutics will be submitted through Emory University

  • Anticipated first cohort: Summer 2023
  • Applications available in Fall 2022

  

The MSBID-AT master’s program is a one-year residential program completed in three sequential semesters over 12 months. Candidates enroll in the summer semester and take a fixed sequence of 30 credit hours: four courses each in the summer, fall, and spring semesters. The curriculum includes strong ethics components throughout. Students also complete a team-based project that mimics the process of real-life product development.